Manchester Capital Management’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.6K | Sell |
128
-1,490
| -92% | -$124K | ﹤0.01% | 813 |
|
|
2025
Q1 | $131K | Hold |
1,618
| – | – | 0.02% | 395 |
|
|
2024
Q4 | $146K | Hold |
1,618
| – | – | 0.02% | 386 |
|
|
2024
Q3 | $160K | Buy |
1,618
+128
| +9% | +$12.6K | 0.02% | 365 |
|
|
2024
Q2 | $138K | Hold |
1,490
| – | – | 0.02% | 374 |
|
|
2024
Q1 | $141K | Hold |
1,490
| – | – | 0.02% | 359 |
|
|
2023
Q4 | $133K | Hold |
1,490
| – | – | 0.02% | 329 |
|
|
2023
Q3 | $109K | Hold |
1,490
| – | – | 0.02% | 344 |
|
|
2023
Q2 | $124K | Buy |
+1,490
| New | +$124K | 0.02% | 324 |
|
|
2021
Q1 | – | Sell |
-40
| Closed | -$6K | – | 800 |
|
|
2020
Q4 | $6K | Hold |
40
| – | – | ﹤0.01% | 522 |
|
|
2020
Q3 | $4K | Hold |
40
| – | – | ﹤0.01% | 455 |
|
|
2020
Q2 | $4K | Hold |
40
| – | – | ﹤0.01% | 511 |
|
|
2020
Q1 | $3K | Hold |
40
| – | – | ﹤0.01% | 507 |
|
|
2019
Q4 | $4K | Hold |
40
| – | – | ﹤0.01% | 494 |
|
|
2019
Q3 | $3K | Hold |
40
| – | – | ﹤0.01% | 497 |
|
|
2019
Q2 | $4K | Hold |
40
| – | – | ﹤0.01% | 524 |
|
|
2019
Q1 | $4K | Sell |
40
-40
| -50% | -$4K | ﹤0.01% | 611 |
|
|
2018
Q4 | $8K | Hold |
80
| – | – | ﹤0.01% | 477 |
|
|
2018
Q3 | $8K | Hold |
80
| – | – | ﹤0.01% | 486 |
|
|
2018
Q2 | $8K | Buy |
+80
| New | +$8K | ﹤0.01% | 491 |
|
|
2015
Q1 | – | Sell |
-546
| Closed | -$34K | – | 915 |
|
|
2014
Q4 | $34K | Hold |
546
| – | – | ﹤0.01% | 798 |
|
|
2014
Q3 | $28K | Hold |
546
| – | – | ﹤0.01% | 836 |
|
|
2014
Q2 | $28K | Hold |
546
| – | – | ﹤0.01% | 809 |
|
|
2014
Q1 | $26K | Hold |
546
| – | – | ﹤0.01% | 734 |
|
|
2013
Q4 | $24K | Sell |
546
-900
| -62% | -$39.6K | ﹤0.01% | 707 |
|
|
2013
Q3 | $62K | Hold |
1,446
| – | – | 0.01% | 554 |
|
|
2013
Q2 | $50K | Buy |
+1,446
| New | +$50K | 0.01% | 602 |
|